You can buy or sell DSGN and other stocks, options, and ETFs commission-free!
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.
52 Week High
52 Week Low
— per share
Expected May 18, Pre-Market